We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Association of the British Pharmaceutical Industry has suspended Astellas UK from the trade group, citing “serious breaches” of the group’s Code of Practice for the Pharmaceutical Industry. Read More
Teva Pharmaceuticals and AstraZeneca have settled patent litigation with a licensing agreement that enables Teva to market and manufacture a generic version of AstraZeneca’s diabetes drug Byetta. Read More
A federal report found opioid spending in Part D Medicare coverage rose to $4.1 billion last year, representing a modest dip in annual spending growth. Read More
The second highest court in the land rejected Mylan’s requested rehearing in two patent lawsuits, leaving the company with few options for avoiding the cases. Read More